Repligen Corp (RGEN) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $126.57 --0%
EPS Growth %: +21.6%
Financial Fact:
Research and development: 1.89M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +21.6%
Financial Fact:
Research and development: 1.89M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Repligen Corp (NASDAQ: RGEN) reported Q2 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $8.63 million versus the consensus estimate of $7.5 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- John Wiley & Sons, Inc. (WLYB) Tops Q4 EPS by 12c; Offers Outlook
- La-Z-Boy (LZB) Tops Q4 EPS by 44c, Beats on Revenue
Create E-mail Alert Related Categories
Earnings, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
